• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Asia Pacific Hospital Acquired Disease Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The Asia Pacific hospital acquired disease testing market is currently witnessing strong growth. Hospital-acquired diseases (HADs), or nosocomial infections, refer to the infections caused by exposure to viral, bacterial and fungal pathogens during hospital visits. Some of the commonly used techniques for testing HADs include the complete blood count (CBC) test, erythrocyte sedimentation rate (ESR) test and urinalysis, which are administered to diagnose catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI) and hospital-acquired pneumonia (HAP).

The rising prevalence of nosocomial infections in the Asia Pacific region is one of the key factors driving the market growth. Being a region majorly populated by developing economies, there is a dire lack of adequate sanitation and related provisions across the healthcare sector, especially in small-scale hospitals and clinics. Consequently, patients are increasingly being exposed to multidrug-resistant bacteria (MDRB) and viruses, which, in turn, is resulting in the growing demand for pathogen detection and other HAD testing procedures. In addition to this, the implementation of favorable government initiatives to promote public health and create awareness regarding the available treatment options for HADs, are contributing to the market growth significantly. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of medical sciences, are anticipated to drive the market further. Looking forward, IMARC Group expects the market to witness robust growth during 2021-2026.?

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific hospital acquired disease testing market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region and indication.

Breakup by Indication:

  • UTI (Urinary Tract Infection)
  • SSI (Surgical Site Infection)
  • Pneumonia
  • Bloodstream Infections
  • MRSA (Methicillin-Resistant Staphylococcus Aureus)
  • Others
     

Breakup by Country:

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key Questions Answered in This Report:

  • How has the Asia Pacific hospital acquired disease testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Asia Pacific hospital acquired disease testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the Asia Pacific hospital acquired disease testing market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Asia Pacific Hospital Acquired Disease Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Indication
    6.1    UTI (Urinary Tract Infection)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    SSI (Surgical Site Infection)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Pneumonia
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Bloodstream Infections
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    MRSA (Methicillin-Resistant Staphylococcus Aureus)
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Country
    7.1    China
        7.1.1 Market Trends
        7.1.2 Market Breakup by Indication
        7.1.3 Market Forecast
    7.2    Japan
        7.2.1 Market Trends
        7.2.2 Market Breakup by Indication
        7.2.3 Market Forecast
    7.3    India
        7.3.1 Market Trends
        7.3.2 Market Breakup by Indication
        7.3.3 Market Forecast
    7.4    South Korea
        7.4.1 Market Trends
        7.4.2 Market Breakup by Indication
        7.4.3 Market Forecast
    7.5    Australia
        7.5.1 Market Trends
        7.5.2 Market Breakup by Indication
        7.5.3 Market Forecast
    7.6    Indonesia
        7.6.1 Market Trends
        7.6.2 Market Breakup by Indication
        7.6.3 Market Forecast
    7.7    Others
        7.7.1 Market Trends
        7.7.2 Market Breakup by Indication
        7.7.3 Market Forecast
8    SWOT Analysis
    8.1    Overview
    8.2    Strengths
    8.3    Weaknesses
    8.4    Opportunities
    8.5    Threats
9    Value Chain Analysis
10    Porters Five Forces Analysis

    10.1    Overview
    10.2    Bargaining Power of Buyers
    10.3    Bargaining Power of Suppliers
    10.4    Degree of Competition
    10.5    Threat of New Entrants
    10.6    Threat of Substitutes
11    Policy and Regulatory Landscape
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players

List of Figures

Figure 1: Asia Pacific: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
Figure 2: Asia Pacific: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015-2020
Figure 3: Asia Pacific: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Asia Pacific: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 5: Asia Pacific: Hospital Acquired Disease Testing Market: Breakup by Country (in %), 2020
Figure 6: Asia Pacific: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 7: Asia Pacific: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 8: Asia Pacific: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Asia Pacific: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Asia Pacific: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Asia Pacific: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Asia Pacific: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Asia Pacific: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Asia Pacific: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Asia Pacific: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Asia Pacific: Hospital Acquired Disease Testing (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Asia Pacific: Hospital Acquired Disease Testing (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: China: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: China: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 20: China: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Japan: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Japan: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 23: Japan: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: India: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: India: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 26: India: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: South Korea: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: South Korea: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 29: South Korea: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 30: Australia: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Australia: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 32: Australia: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 33: Indonesia: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Indonesia: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 35: Indonesia: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Others: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Others: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia Pacific: Hospital Acquired Disease Testing Industry: SWOT Analysis
Figure 39: Asia Pacific: Hospital Acquired Disease Testing Industry: Value Chain Analysis
Figure 40: Asia Pacific: Hospital Acquired Disease Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Asia Pacific: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2020 and 2026
Table 2: Asia Pacific: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Asia Pacific: Hospital Acquired Disease Testing Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 4: Asia Pacific: Hospital Acquired Disease Testing Market: Competitive Structure
Table 5: Asia Pacific: Hospital Acquired Disease Testing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links